Premium Tirofiban Hydrochloride API in Pakistan: Reliable Raw Material Supply for Pharmaceutical Formulators

Product Name: Tirofiban Hydrochloride (Active Pharmaceutical Ingredient)

Supplier / Distributor: Morgan

Therapeutic Category: Antiplatelet Agent / Glycoprotein IIb/IIIa Receptor Antagonist

Indications: Acute Coronary Syndrome (ACS), Unstable Angina, Myocardial Infarction (NSTEMI)

Compliance Notice: This technical data page is strictly for B2B pharmaceutical manufacturers, contract manufacturing organizations (CMOs), and analytical laboratories. The Tirofiban Hydrochloride distributed by Morgan is a highly purified Active Pharmaceutical Ingredient (API) intended exclusively for commercial formulation and laboratory R&D. It is not a finished drug product.

About Morgan: Morgan Chemicals (Pvt.) Ltd. is a pharmaceutical raw material trading and distribution company. We source APIs from DRAP-registered and internationally certified manufacturers and supply exclusively to licensed pharmaceutical companies, CMOs, and research facilities. We do not manufacture APIs or sell finished medicines.

Product Overview and Mechanism of Action

Tirofiban Hydrochloride is a highly potent, non-peptide small-molecule Active Pharmaceutical Ingredient (API). In cardiovascular pharmacology, it is classified as a reversible glycoprotein (GP) IIb/IIIa receptor antagonist. For pharmaceutical manufacturers developing critical care and emergency cardiovascular therapeutics, this API is essential for preventing thrombotic complications.

At the cellular level, the pathogenesis of acute coronary syndrome involves the rupture of atherosclerotic plaques, which triggers rapid platelet aggregation and subsequent thrombus formation. Tirofiban acts directly at the final common pathway of this aggregation process. It competitively inhibits the binding of fibrinogen and von Willebrand factor to the GP IIb/IIIa receptors located on the surface of activated human platelets.

By reversibly occupying these receptor sites, Tirofiban physically prevents adjacent platelets from cross-linking, thereby halting the formation of blood clots in the coronary arteries. Because its mechanism is highly targeted and reversible, it offers a predictable pharmacokinetic profile.

For pharmaceutical formulation scientists, integrating this API requires specific expertise in parenteral drug development. In commercial manufacturing, this active ingredient is formulated exclusively as a sterile, aqueous solution intended for intravenous (IV) infusion, typically administered to patients undergoing percutaneous coronary intervention (PCI).

Sourcing Tirofiban Hydrochloride in Pakistan: Morgan’s Supply Network

Developing and commercializing sterile, life-saving cardiovascular intravenous formulations requires a highly resilient, traceable, and quality-assured raw material pipeline. Procuring specialized parenteral-grade APIs for local manufacturing frequently involves navigating extended lead times, stringent customs protocols, and demanding regulatory compliance. Sourcing TIROFIBAN HYDROCHLORIDE Pakistan through Morgan’s localized distribution network mitigates these complex supply chain risks.

Morgan sources commercial-scale and pilot-scale quantities from global manufacturing partners operating in strict adherence to ICH Q7 Good Manufacturing Practice (GMP) guidelines for active pharmaceutical ingredients. Partnering with Morgan as your primary supply vendor secures several operational provisions for your manufacturing facility:

• DRAP Submission Assistance: Morgan coordinates with DRAP-registered API manufacturers to obtain and forward the necessary compliance documentation on your behalf. This includes the open part of the Drug Master File (DMF), comprehensive impurity profiles, accelerated stability data, and endotoxin control records to directly support your Drug Regulatory Authority of Pakistan (DRAP) dossier submissions.
• Supply Chain Stability: Our localized API inventory management eliminates international transit variables. Whether you require a standard clinical batch or are scaling up a high-volume TIROFIBAN HYDROCHLORIDE api Pakistan procurement order, we guarantee that your commercial production timelines are met without costly line stoppages.
• Batch-to-Batch Uniformity: Every shipment coordinated by Morgan includes a detailed Certificate of Analysis (CoA) issued by the original manufacturer. We ensure our supplied batches maintain consistent chemical purity, precise moisture limits, and strict bioburden controls required for sterile compounding and aseptic filling processes.

Technical Specifications for QA & R&D

The Tirofiban Hydrochloride API supplied by Morgan undergoes exacting analytical testing at the source to meet current international pharmacopeial (USP/EP) standards.

• Chemical Name: N-(butylsulfonyl)-O-[4-(4-piperidinyl)butyl]-L-tyrosine monohydrochloride monohydrate
• CAS Number: 150915-40-5 (Monohydrate)
• Appearance: White to off-white crystalline powder
• Molecular Formula: C22H36ClN3O5S · H2O
• Molecular Weight: 514.08 g/mol (Monohydrate)
• Assay / Purity (HPLC): ≥ 99.0%
• Solubility Profile: Freely soluble in water and slightly soluble in specific organic solvents. Detailed solubility parameters and pH-dependent stability data are documented in the technical data sheet to assist your analytical R&D teams with IV solution buffering and osmolarity adjustments.

Manufacturing and Handling Guidelines for Formulators

As an antiplatelet medication, Tirofiban is a highly potent, pharmacologically active compound. Furthermore, because its intended finished dosage form is a parenteral infusion, facilities processing this API must enforce strict environmental controls and occupational exposure limits (OEL).

• Storage Conditions: Store the raw API powder in securely closed, light-resistant containers. Maintain climate-controlled conditions as specified by the batch protocol (typically controlled room temperature, protected from excessive heat and ambient humidity) to prevent degradation.
• Occupational Safety and Aseptic Processing: Personnel handling the pure API powder must follow advanced industrial containment protocols. Processing requires appropriate Personal Protective Equipment (PPE), including P3/N95 industrial respirators and chemical-resistant nitrile gloves. Because the final product is an IV solution, the dispensing, compounding, and liquid filling stages must be executed within highly controlled cleanroom environments (ISO Class 5/Class A) under laminar flow hoods or restricted access barrier systems (RABS) to guarantee absolute sterility and prevent endotoxin contamination.

Distributor Disclaimer: Morgan Chemicals is a pharmaceutical raw material trading and distribution company. This API is sourced from DRAP-registered, GMP-certified manufacturing partners. Morgan Chemicals does not manufacture APIs, does not hold DRAP manufacturing registration, and does not sell finished medicines. This product is supplied exclusively to licensed pharmaceutical companies, CMOs, and research facilities in Pakistan — not for individual or consumer sale.